342
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Skin and Sural Nerve Biopsies: Ultrastructural Findings in the First Genetically Confirmed Cases of CADASIL in Serbia

, MD, PhD, , MD, PhD, , MD, MSc, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, PhD & , MD, PhD show all
Pages 325-335 | Received 15 Feb 2012, Accepted 14 Mar 2012, Published online: 01 Oct 2012

REFERENCES

  • Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993;3:256–259.
  • Kalimo H, Ruchoux M-M, Viitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 2002;12:371–384.
  • Haritunians T, Chow T, De Lange RPJ, et al. Functional analysis of a recurrent missense mutation in Notch3 in CADASIL. J Neurol Neurosurg Psychiatry. 2005;76:1242–1248.
  • Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346:934–939.
  • Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731–739.
  • Monet-Lepretre M, Bardot B, Lemaire B, et al. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain. 2009;132:1601–1612.
  • Reyes S, Viswanathan A, Godin O, et al. Apathy: a major symptom in CADASIL. Neurology. 2009;72:905–910.
  • Baudrimont M, Dubas F, Joutel A et al. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke: a clinicopathological study. Stroke. 1993;24:122–125.
  • Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707–710.
  • Fouillade C, Chabriat H, Riant F, et al. Activating NOTCH3 mutations in a patient with small-vessel-disease of the brain. Hum Mut. 2008;29:452–462.
  • Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134:2709–2718.
  • Ruchoux MM, Guerouaou D, Vandenhaute B, et al. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. 1995;89:500–512.
  • Ebke M, Dichgans M, Bergmann M, et al. CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand. 1997;95:351–357.
  • Rouchoux MM, Guerouaou D, Vandehaute B, et al. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. 1995;80:500–512.
  • Mayer M, Straube A, Bruening R, et al. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol. 1999;246:526–532.
  • Schröder JM, Sellhaus B, Jorg J. Identification of the characteristic vascular changes in a sural nerve biopsy of a case with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Acta Neuropathol. 1995;89:116–121
  • Schröder J, Züchner S, Dichgans M, Nagy Z, Molnar M. Peripheral nerve and skeletal muscle involvement in CADASIL. Acta Neuropathol. 2005;110:587–599.
  • Lackovic V, Bajcetic M, Kostic V, et al. Ultrastructural analysis of small blood vessels in skin biopsies in CADASIL. Proceedings of the 3rd Serbian Congress for Microscopy, September 25–28, 2007, Belgrade, Serbia. 2007:207–208.
  • Zidverc-Trajkovic J, Lackovic V, Pavlovic A, et al. [Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)—three case reports from Serbia]. Srp Arh Celok Lek. 2008;136: 148–153.
  • Sternic N, Pavlovic A, Miljic P, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy with severe factor XII deficiency. Neurol Ind. 2009; 57: 657–659.
  • Lackovic V, Bajcetic M, Sternic N, et al. Ultrastructural analysis of small blood vessels in skin biopsies in CADASIL. Arch Biol Sci. 2008; 60: 573–580.
  • Bajcetic M. Značaj ultrastrukturalnih istraživanja dermisa, mišića i suralnog nerva u diferencijalnoj dijagnozi bolesti malih i srednjih krvnih sudova nervnog sistema [The Importance of Ultrastructural Research of Dermis, Muscle and Sural Nerve in the Differential Diagnosis of Small and Medium-sized Blood Vessel Diseases of the Nervous System]. Thesis, Faculty of Medicine, University of Belgrade, Belgrade, 2010.
  • Lackovic V, Japundzic M, Vuzevski V, et al. Use of silver methenamine staining in the study of the dark cell-light cell phenomenon. Med Sci Res. 1990;18:615–616.
  • Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
  • Coto E, Menendez M, Navarro R, et al. A new de novo Notch3 mutation causing CADASIL. Eur J Neur. 2006;13:628–631.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psych Res. 1975;12:189–198.
  • Lackovic M. Psihijatrijski poremećaji kod bolesnika sa naslednim bolestima malih krvnih sudova mozga [Psychiatric Disorders in Patients with Hereditary Small Blood Vessel Diseases of the Brain]. Thesis, Faculty of Medicine, University of Belgrade, Belgrade, 2010.
  • Bousser MG, Tournier-Lasserve E. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: from stroke to vessel wall physiology. J Neurol Neurosurg Psychiatry. 2001;70:285–287.
  • Kalimo H, Miao Q, Tikka S, et al. CADASIL: the most common hereditary subcortical vascular dementia. Future Neurol. 2008; 3: 683–704.
  • Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurol. 2009; 8: 643–653.
  • Lackovic M, Damnjanovic A, Jasovic-Gasic M, et al., CADASIL—Psihijatrijski aspekti. Engrami 2008;30:31–40.
  • O’Sullivan M, Jarosz JM, Martin RJ, et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001; 56: 628–634.
  • Joutel A, Favrole P, Labauge P, et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet. 2001; 358:2049–2051.
  • Lesnik Oberstein SA, van Duinen SG, van den Boom R, et al. Evaluation of diagnostic NOTCH3 immunostaining in CADASIL. Acta Neuropathol. 2003; 106:107–111.
  • Kalaria RN, Viitanen M, Kalimo H, et al. The pathogenesis of CADASIL: an update. J Neurol Sci. 2004; 226:35–39.
  • Tikka S, Mykkanen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain. 2009;132:933–939.
  • Furby A, Vahedi K, Force M, et al. Differential diagnosis of a vascular leukoencephalopathy within a CADASIL family: use of skin biopsy electron microscopic study and direct genotypic screening. J Neurol. 1998;245:734–740.
  • Schultz A, Santoianni R, Hewan-Lowe K, Stern B, Hunter S. Vasculopathic changes of CADASIL can be focal in skin biopsies. Ultrastruct Pathol. 1999;23:241–247.
  • Ruchoux MM, Maurage CA. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 1997;56:947–964.
  • Dichgans M. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: phenotypic and mutational spectrum. J Neurol Sci. 2002;203–204:77–80.
  • Ungaro C, Mazzei R, Conforti FL, et al. CADASIL: extended polymorphisms and mutational analysis of the NOTCH3 gene. J Neurosci Res. 2009;87:1162–1167.
  • Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511–1515.
  • Federico A, Bianchi S, Dotti MT. The spectrum of mutations for CADASIL diagnosis. J Neurol Sci. 2005;26:117–124.
  • Tuominen S, Miao Q, Kurki T, et al. Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke. 2004;35:1063–1067.
  • Opherk C, Peters N, Herzog J, et al. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127:2533–2539.
  • Okeda R, Arima K, Kawai M. Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case. Stroke. 2002;33:2565–2569
  • Miao Q, Paloneva T, Tuominen S, et al. Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathol. 2004;14:358–364.
  • Chabriat H, Pappata S, Ostergaard L, et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke. 2000;31:1904–1912.
  • Staekenborg SS, Su T, van Straaten ECW, et al. Behavioural and psychological symptoms in vascular dementia: differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry. 2010;81:547–551.
  • Joutel AS, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000;105:597–605.
  • Ishiko A, Shimizu A, Nagata E, et al. Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol. 2006;112:333–339.
  • Takahashi K, Adachi K, Yoshizaki K, et al. Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Hum Mol Genet. 2010;19:79–89.
  • Joutel A. Pathogenesis of CADASIL: transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3, in the cerebrovasculature. Bioessays. 2011;33:73–80.
  • Kalimo H, Viitanen M, Amberla K, et al. CADASIL: hereditary disease of arteries causing brain infarcts and dementia. Neuropathol Appl Neurobiol. 1999;25:257–265.
  • Dziewulska D. Mysteries of CADASIL—the contribution of neuropathology to understanding of the disease. Folia Neuropathol. 2009;47:1–10.
  • Widlak P, Palyvoda O, Kumala S, Garrard WT. Modeling apoptotic chromatin condensation in normal cell nuclei. J Biol Chem. 2002;277:21683–21690.
  • Szpak GM, Lewandowska E, Wierzba-Bobrowicz T, et al. Small cerebral vessel disease in familial amyloid and nonamyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies. Folia Neuropathol. 2007;45:192–204.
  • Domenga V, Fardoux P, Lacombe P, et al. Notch 3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004;18:2730–2735.
  • Gray F, Polivka M, Viswanathan A, Baudrimont M, Bousser MG, Chabriat H. Apoptosis in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 2007;66:597–607.
  • Scaffidi P, Gordon L, Misteli T. The cell nucleus and aging: tantalizing clues and hopeful promises. PLoS Biol. 2005;3:e395.
  • Wehnert MS, Bonne G. The nuclear muscular dystrophies. Semin Pediatr Neurol. 2002;9:100–107.
  • Maraldi NM, Capanni C, Cenni V, et al. Laminopathies and lamin-associated signaling pathways. J Cell Biochem. 2011;112:979–992.
  • Dahl KN, Scaffidi P, Islam MF, et al. Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2006;103:10271–10276.
  • Hernandez L, Roux KJ, Wong ES, et al. Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell. 2010;19:413–425.
  • Liu D, Ou L, Clemenson GD, et al. Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol. 2010;12:993–998.
  • Marji J, O’Donoghue SI, McClintock D, et al. Defective lamin A-Rb signaling in Hutchinson–Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition. PLoS ONE. 2010;5:e11132.
  • Scaffidi P, Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol. 2008;10:452–459.
  • Goldman RD, Shumaker DK, Erdos MR, et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford Progeria Syndrome. Proc Natl Acad Sci U S A. 2004;101:8963–8968.
  • Andres V, Gonzalez JM. Role of A-type lamins in signaling, transcription, and chromatin organization. J Cell Biol. 2009;187:945–957.
  • Schröder JM. Neuropathology of Charcot-Marie-Tooth and related disorders. Neuromol Med. 2006;8:23–42
  • Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry. 2000;68:483–488.
  • Sicurelli F, Dotti MT, De Stefano N, et al. Peripheral neuropathy in CADASIL. J Neurol. 2005;252:1206–1209.
  • Kang S-Y, Oh J-H, Kang J-H, Choi JC, Lee JS. Nerve conduction studies in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neurol. 2009;256:1724–1727.
  • Grehl H, Schröder JM. Significance of degenerating endoneurial cells in peripheral neuropathy. Acta Neuropathol. 1991;81:680–685.
  • Powell HC, Rosoff J, Myers RR. Microangiopathy in human diabetic neuropathy. Acta Neuropathol. 1985;68:295–305.
  • Kim J-M, Lee T-H, Lee M-C, et al. Endoneurial microangiopathy of sural nerve in experimental vacor-induced diabetes. Ultrastruct Pathol. 2002;26:393–401.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.